Cargando…

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines

Detalles Bibliográficos
Autores principales: Kozak, Kathryn E., Ouyang, Linda, Derkach, Andriy, Sherman, Alexandra, McCall, Susan J., Famulare, Christopher, Chervin, Jordan, Daley, Ryan J., Morjaria, Sejal, Mauro, Michael J., Rampal, Raajit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569492/
https://www.ncbi.nlm.nih.gov/pubmed/34741117
http://dx.doi.org/10.1038/s41375-021-01457-1
_version_ 1784594651733295104
author Kozak, Kathryn E.
Ouyang, Linda
Derkach, Andriy
Sherman, Alexandra
McCall, Susan J.
Famulare, Christopher
Chervin, Jordan
Daley, Ryan J.
Morjaria, Sejal
Mauro, Michael J.
Rampal, Raajit K.
author_facet Kozak, Kathryn E.
Ouyang, Linda
Derkach, Andriy
Sherman, Alexandra
McCall, Susan J.
Famulare, Christopher
Chervin, Jordan
Daley, Ryan J.
Morjaria, Sejal
Mauro, Michael J.
Rampal, Raajit K.
author_sort Kozak, Kathryn E.
collection PubMed
description
format Online
Article
Text
id pubmed-8569492
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85694922021-11-05 Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines Kozak, Kathryn E. Ouyang, Linda Derkach, Andriy Sherman, Alexandra McCall, Susan J. Famulare, Christopher Chervin, Jordan Daley, Ryan J. Morjaria, Sejal Mauro, Michael J. Rampal, Raajit K. Leukemia Letter Nature Publishing Group UK 2021-11-05 2021 /pmc/articles/PMC8569492/ /pubmed/34741117 http://dx.doi.org/10.1038/s41375-021-01457-1 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter
Kozak, Kathryn E.
Ouyang, Linda
Derkach, Andriy
Sherman, Alexandra
McCall, Susan J.
Famulare, Christopher
Chervin, Jordan
Daley, Ryan J.
Morjaria, Sejal
Mauro, Michael J.
Rampal, Raajit K.
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title_full Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title_fullStr Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title_full_unstemmed Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title_short Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
title_sort serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with sars-cov-2 spike protein messenger rna (mrna) vaccines
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569492/
https://www.ncbi.nlm.nih.gov/pubmed/34741117
http://dx.doi.org/10.1038/s41375-021-01457-1
work_keys_str_mv AT kozakkathryne serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT ouyanglinda serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT derkachandriy serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT shermanalexandra serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT mccallsusanj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT famularechristopher serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT chervinjordan serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT daleyryanj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT morjariasejal serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT mauromichaelj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines
AT rampalraajitk serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines